NCT02738970 A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC) Status COMPLETED Phase PHASE1
NCT02736721 Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML) Status COMPLETED Phase PHASE3
NCT02733419 Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection Status COMPLETED Phase PHASE3
NCT02732639 A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) Status COMPLETED Phase PHASE3
NCT02731313 Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma Status COMPLETED Phase N/A
NCT02731131 A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) Status COMPLETED Phase PHASE2
NCT02729896 A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE1/PHASE2
NCT02726022 A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels Status COMPLETED Phase N/A
NCT02723071 A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL) Status COMPLETED Phase PHASE1/PHASE2
NCT02721641 A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer Status COMPLETED Phase PHASE3
NCT02721004 Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02720120 A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA) Status TERMINATED Phase PHASE1/PHASE2
NCT02717754 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02717689 A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma Status COMPLETED Phase NA
NCT02716792 A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer Status COMPLETED Phase PHASE3
NCT02716779 Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection Status COMPLETED Phase PHASE2
NCT02715531 A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors Status COMPLETED Phase PHASE1
NCT02711423 A Single-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Gantenerumab Following Subcutaneous (SC) Administration in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02707640 A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2